136 related articles for article (PubMed ID: 31904327)
21. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
Sapam R; Agrawal S; Dhali TK
Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369
[TBL] [Abstract][Full Text] [Related]
22. Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial.
El Mofty M; Bosseila M; Mashaly HM; Gawdat H; Makaly H
Clin Exp Dermatol; 2013 Dec; 38(8):830-5. PubMed ID: 23551324
[TBL] [Abstract][Full Text] [Related]
23. Epidermoid carcinoma of the gingiva: a possible relationship to PUVA therapy.
Krutchkoff DJ; Eisenberg E; Neckritz AA
Oral Surg Oral Med Oral Pathol; 1981 Jul; 52(1):44-50. PubMed ID: 6944677
[TBL] [Abstract][Full Text] [Related]
24. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides.
El-Mofty M; Mostafa WZ; Bosseila M; Youssef R; Esmat S; El Ramly A; Fawzi M; Mahgoub D; Nagui N; Mashaly HM; El-Fangary M; Fathy M
Dermatol Ther; 2010; 23(4):428-34. PubMed ID: 20666832
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous carcinoma and PUVA lentigines in Thai patients treated with oral PUVA.
Gritiyarangsan P; Sindhavananda J; Rungrairatanaroj P; Kullavanijaya P
Photodermatol Photoimmunol Photomed; 1995 Aug; 11(4):174-7. PubMed ID: 8850252
[TBL] [Abstract][Full Text] [Related]
26. PUVA therapy.
Helm TN; Dijkstra JW; Ferrara RJ; Glanz S
Am Fam Physician; 1991 Mar; 43(3):908-12. PubMed ID: 2000735
[TBL] [Abstract][Full Text] [Related]
27. p53 immunoreactivity in cutaneous PUVA tumors is similar to that in other non-melanoma skin neoplasms.
Proby CM; du Peloux Menagé H; McGregor JM; Hobbs C; Norris PG; Smith N; Hawk JL; McKee PH
J Cutan Pathol; 1993 Oct; 20(5):435-41. PubMed ID: 8300928
[TBL] [Abstract][Full Text] [Related]
28. Widespread cutaneous carcinomas associated with human papillomaviruses 5, 14 and 20 after introduction of methotrexate in two long-term PUVA-treated patients.
Zumtobel U; Schwarze HP; Favre M; Taïeb A; Delaunay M
Dermatology; 2001; 202(2):127-30. PubMed ID: 11306834
[TBL] [Abstract][Full Text] [Related]
29. An objective assessment of melanin in vitiligo skin treated with Balneo PUVA therapy.
Hegyi V; Petrovajová M; Novotný M
Skin Res Technol; 2014 Feb; 20(1):108-15. PubMed ID: 23800185
[TBL] [Abstract][Full Text] [Related]
30. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
Vussuki E; Ziv M; Rosenman D; David M
Harefuah; 2006 Jul; 145(7):483-5, 552, 551. PubMed ID: 16900734
[TBL] [Abstract][Full Text] [Related]
31. [Actinic keratoses--sequelae of long-term PUVA therapy].
Westphal HJ; Wurdel C; Flegel H
Dermatol Monatsschr; 1989; 175(10):623-7. PubMed ID: 2512186
[TBL] [Abstract][Full Text] [Related]
32. Treatment of vitiligo with oral methoxsalen and UVA.
Lassus A; Halme K; Eskelinen A; Ranki A; Puska P; Salo O
Photodermatol; 1984 Aug; 1(4):170-3. PubMed ID: 6531291
[TBL] [Abstract][Full Text] [Related]
33. 5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo.
McNeely W; Goa KL
Drugs; 1998 Oct; 56(4):667-90. PubMed ID: 9806110
[TBL] [Abstract][Full Text] [Related]
34. The ultraviolet fingerprint dominates the mutational spectrum of the p53 and Ha-ras genes in psoralen + ultraviolet A keratoses from psoriasis patients.
Wolf P; Kreimer-Erlacher H; Seidl H; Bäck B; Soyer HP; Kerl H
J Invest Dermatol; 2004 Jan; 122(1):190-200. PubMed ID: 14962108
[TBL] [Abstract][Full Text] [Related]
35. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
36. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
37. Multiple actinic keratoses and squamous cell carcinomas on the sun-exposed areas of widespread vitiligo.
Akimoto S; Suzuki Y; Ishikawa O
Br J Dermatol; 2000 Apr; 142(4):824-5. PubMed ID: 10792246
[No Abstract] [Full Text] [Related]
38. Is the combination of calcipotriol and PUVA effective in vitiligo?
Baysal V; Yildirim M; Erel A; Kesici D
J Eur Acad Dermatol Venereol; 2003 May; 17(3):299-302. PubMed ID: 12702070
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of local psoralen ultraviolet A treatments in psoriasis, vitiligo and eczema.
Adişen E; Karaca F; Oztaş M; Gürer MA
Clin Exp Dermatol; 2008 May; 33(3):344-5. PubMed ID: 18093241
[No Abstract] [Full Text] [Related]
40. Narrow band Ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies.
El Mofty M; Mostafa W; Esmat S; Youssef R; Azzam O; Hunter N; El Hanafi G; Fawzi M
Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):6-11. PubMed ID: 16436175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
